Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adastra, Arcutis, Celltrion, Cytokinetics, Fosun, Gensight, Jounce, Kintara, Leo, Philogen, Regeneron, Rockwell, Sanofi, Sorrento, Synairgen.

Biopharmas raising money in public or private financings, including: Acorda, Affimed, Cerecor, Cullinan, Jaguar Health, Provention, Regenxbio, Sana, Theradaptive.

New hires and promotions in the biopharma industry, including: Artios, Immunovant, Intelgenx, Tiziana.

The latest global regulatory news, changes and updates affecting biopharma.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: AM, Arch Biopartners, Aslan, Atyr, Basilea, Cerecor, Codagenix, Creative Medical Technology, Dalcor, Dr. Reddy’s, Edesa, Immutep, Kintor, Mesoblast, Neurorx, Quantum Leap Healthcare, Relief, Russian Direct Investment Fund, Sanbio, Serum Institute of India, Windtree.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 3D Medicines, Abbvie, Aerpio, Aim Immunotech, Akston, Alteogen, Ana, Argenx, Baxter Biopharma Solutions, Biohaven, Biontech, Bold, Cheplapharm Arzneimittel, Cohbar, Cristal, Curevac, Emergex Vaccines, Fujifilm, Geovax Labs, Humanigen, Iacta, Immunitybio, Intas, Intravacc, Iovaxis, Kleo, Legochem, Merck KGaA, Microsoft, Moderna, Nantkwest, Neurobo, Novavax, Peptidream, Pfizer, Pharmabcine, Pharmaleads, SK Chemicals, Sosei Group, Standigm, Takeda, Targovax, Y-Biologics, Zai Lab.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Ascendis, Gracell, Ligature, Paratek, Revelation Biosciences, Visen, Zai Lab.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Antengene, Apollomics, Arcturus, Ascentage, Astellas, Astrazeneca, Atriva, Everest Medicines, Glaxosmithkline, Glycomimetics, Moderna, Neuren, Russian Direct Investment Fund, Shenzhen Chipscreen Biosciences, Visen Pharmaceuticals Shanghai.

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: CMS finalizes MCIT rule; HHS lists permanent waivers of notification; FDA schedules advisory meeting for latest Lutonix model; HHS announces telehealth grants; Telemarketer caught in sting over telehealth fraud; Churn at FDA chief counsel’s office.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Biomerica, Cognito Therapeutics, Cytosorbents, Jud Care, Medskin Solutions Dr. Suwelack, Microvention, Ortho, Quanterix, Therapixel.